Hepatitis B virus downregulates vitamin D receptor levels in hepatoma cell lines, thereby preventing vitamin D-dependent inhibition of viral transcription and production
Open Access
- 16 October 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular Medicine
- Vol. 24 (1), 53
- https://doi.org/10.1186/s10020-018-0055-0
Abstract
Vitamin D is a key immune-modulator that plays a role in the innate and adaptive immune systems. Certain pathogens impair the immune defense by downregulating the vitamin D receptor (VDR) pathway. Low serum levels of vitamin D are associated with increased hepatitis B virus (HBV) replication. Our study aimed to assess the in-vitro relationship between HBV production and Vitamin D signaling pathway and to explore the associated mechanism(s). HBV transcription and replication was evaluated by qRT-PCR of the HBV-RNA and covalently closed circular DNA (cccDNA). Furthermore, we have transfected the 1.3 X HBV-Luc plasmid to the cells and measured the Luciferase activity using Luminometer. Vitamin D signaling pathway activation was evaluated by measuring the expression levels of VDR, CYP24A1, Tumor necrosis factor α (TNFα) and cathelicidin (CAMP) by qRT-PCR. All assays were performed on HepG2.2.15, HepG2, and HepAD38 cells treated with or without Vitamin D active metabolite: calcitriol. Calcitriol did not suppress HBV transcription, cccDNA expression or HBV RNA levels in HepG2.2.15 cells. However, VDR transcript levels in HepG2.215 cells were significantly lower compared to HepG2 cells. Similar results were obtained in HepAD38 cell where VDR expression was down-regulated when HBV transcript level was up-regulated. In addition, calcitriol induced VDR-associated signaling, resulting in upregulation of CYP24A1, TNFα and CAMP expression level in HepG2 cells but not in the HepG2.2.15 cells. These findings indicate that VDR expression is downregulated in HBV-transfected cells, thereby preventing vitamin D from inhibiting transcription and translation of HBV in vitro. HBV might use this mechanism to avoid the immunological defense system by affecting both TNFα and CAMP signaling pathways.This publication has 44 references indexed in Scilit:
- Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up studyThe Lancet, 2013
- Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinomaNature Reviews Cancer, 2013
- Association between vitamin D and hepatitis C virus infection: A meta-analysisWorld Journal of Gastroenterology, 2013
- Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patientsWorld Journal of Gastroenterology, 2011
- Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis CTransplant International, 2010
- Curcumin inhibits hepatitis B virus via down‐regulation of the metabolic coactivator PGC‐1αFEBS Letters, 2010
- The vitamin D–antimicrobial peptide pathway and its role in protection against infectionFuture Microbiology, 2009
- Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat1Journal of General Virology, 2007
- Enhancement of Hepatitis B Virus Replication by the Regulatory X Protein In Vitro and In VivoJournal of Virology, 2007
- Vitamin D–induced up–regulation of tumour necrosis factor alpha (TNF–α) in prostate cancer cellsLife Sciences, 2005